NeuroPace (NPCE) Cost of Revenue (2020 - 2026)
NeuroPace (NPCE) posted quarterly Cost of Revenue of $4.0 million for Q1 2026, down 22.42% year-over-year from $5.2 million in Q1 2025, and down 33.11% quarter-over-quarter from $6.0 million in Q4 2025.
NeuroPace (NPCE) Cost of Revenue (2020 - 2026) Analysis & Trends
NeuroPace's Cost of Revenue history runs 7 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Cost of Revenue fell 22.42% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $21.6 million (up 1.8% YoY), while the FY2025 annual figure was $22.8 million, up 9.34% from the prior year.
- Cost of Revenue for Q1 2026 stood at $4.0 million, down from $6.0 million in the prior quarter.
- The five-year high for Cost of Revenue was $6.2 million in Q3 2025, with the low at $2.7 million in Q2 2022.
- The 5-year median for Cost of Revenue is $4.5 million (2023), against an average of $4.6 million.
- The sharpest annual moves came in 2023 and 2026: Cost of Revenue surged 65.98% in 2023, then declined 22.42% in 2026.
- NeuroPace's Cost of Revenue stood at $4.0 million in 2022, then advanced by 12.07% to $4.5 million in 2023, then gained by 18.16% to $5.3 million in 2024, then grew by 13.87% to $6.0 million in 2025, then slumped by 33.11% to $4.0 million in 2026.
- Business Quant data shows NPCE's Cost of Revenue at $4.0 million in Q1 2026, $6.0 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 808.60 Mn |
| 10 | NeuroPace | 470.30 Mn | 418.60 Mn | 18.91 Mn | 3.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Mn |
| Jun 30, 2026 | 3.92 Mn |
| Mar 31, 2026 | 4.02 Mn |
| Mar 31, 2026 | 4.02 Mn |
| Dec 31, 2025 | 6.01 Mn |
| Dec 31, 2025 | 6.01 Mn |
| Sep 30, 2025 | 6.19 Mn |
| Sep 30, 2025 | 6.19 Mn |
| Jun 30, 2025 | 5.39 Mn |
| Jun 30, 2025 | 5.39 Mn |
| Mar 31, 2025 | 5.18 Mn |
| Mar 31, 2025 | 5.18 Mn |
| Dec 31, 2024 | 5.28 Mn |
| Dec 31, 2024 | 5.28 Mn |
| Sep 30, 2024 | 5.64 Mn |
| Sep 30, 2024 | 5.64 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | 4.78 Mn |
| Mar 31, 2024 | 4.78 Mn |